By Washington Post Eva Dou, Isabelle Khurshudyan NATIONAL, WORLD, HEALTH, SCIENCE-ENVIRONMENT, HEALTH-NEWS
205 publications
Sinopharm of China announced this week that it would deliver emergency doses of one of its two control vaccines in the United Arab Emirates, prioritizing America’s best friend over the vast majority of Chinese. China is now the provider of the coronavirus vaccine in the Middle East. .
Meanwhile, the Russian sovereign fund signed an agreement this week to supply India with one hundred million doses of the Sputnik V vaccine.
These measures have unbalanced Western policy makers. Fitness experts say the United States is not rushing to respond to its own vaccine, but this leaves China and Russia as the only countries that will use this valuable diplomatic tool in the coming months.
The result is that until next year, China and Russia would possibly have bought significant geopolitical force by circumventing regulations and hastening their vaccines. It is also imaginable that your vaccines will fail, at a massive human cost.
“This is crazy and a terrible idea,” said Arthur Caplan, director of the medical ethics department at Grossman School of Medicine at New York University, China and Russia, without waiting for the effects of phase 3 trials. “It’s incredibly hard to understand. “
Kirill Dmitriev, director of the Russian Direct Investment Fund, which funded Russia’s immunization efforts, said Russia’s resolve to deploy Sputnik V before the final touch of the Phase 3 tests has been validated through other countries that now do the same.
“The complaint that you can’t sign a vaccine until phase 3,” Dmitriev said. “But after that, China signed a vaccine, the United Arab Emirates signed a vaccine before the final touch of Phase 3, and Britain and the United States have publicly stated that they plan to sign a vaccine before phase 3, so that component of the complaint has disappeared. “
In recent days, President Donald Trump has pushed for a faster American vaccine, while U. S. pharmaceutical corporations have resisted the concept of taking a shortcut around fashion security protocols.
Hundreds of thousands of others in China, as well as diplomats, army personnel, frontline fitness personnel and state-owned personnel, obtained Sinopharm vaccines in urgent use situations, according to state media last week. the country awaits access, Beijing has begun deploying vaccines in regions where it seeks to expand its influence.
In addition to working with the United Arab Emirates, Sinopharm is conducting phase 3 trials in Jordan and Bahrain.
Egypt announced on 11 September that it would also begin trials with Sinopharm, 3 days after Anglo-Swedish drug manufacturer AstraZeneca discontinued its clinical trial due to a “potentially unexplained disease”. an agreement with AstraZeneca in July to buy 30 million doses of its vaccine.
Caplan said of those geopolitical dynamics: “Yes, that’s a problem. “
Officials in Moscow said this week that initial doses of the Sputnik V vaccine had been delivered to all regions of Russia, and that fitness personnel and teachers were the first to do so.
India, Brazil, Mexico and Kazakhstan have agreed on Sputnik V.
For China, these movements are a massive gamble, as a country of origin for the new coronavirus, it sought to make amends and curb foreign fury, but some of its previous efforts failed, for example, when lots of face masks and other non-public ones. appliances exported from China proved defective.
What is at stake is much more important with vaccines. Doctors say there is a threat of rare but serious side effects that are not provided in small-scale trials, so large-scale Phase 3 trials are conducted for months before the sale of a vaccine is approved. due to hasty manufacturing.
But if China’s commitment pays off, if its vaccines turn out and are effective, it may only consolidate its leadership over the West in economic recovery in 2021, while using the vaccine as a tough diplomatic tool.
Even if China and Russia accelerate vaccine launches, there may not be enough doses for everyone, which will require priority decisions. Both countries can produce enough vaccine in the first year for a fraction of their population.
China has a total of 4 covid-19 vaccine applicants in Phase 3, and its brands have been dispersed around the world for testing. The leaders explained that China had so few cases of covid-19 that it is difficult to conduct trials at home.
But these tests have also been diplomatically convenient for Beijing, as it is necessarily a quick pass to vaccines that China can offer emerging countries: Saudi Arabia, Argentina, Bahrain, Brazil, Bangladesh, Egypt, Indonesia, Jordan, Morocco, Peru, Russia and the United Arab Emirates are the countries that have registered for Phase 3 trials of Chinese vaccines opposed to Covid-19.
The Russian Direct Investment Fund said it expects 30 million doses to occur in Russia until the end of the year, enough for about 20% of the population.
But while the doses of Sputnik V produced in the country will be reserved for the Russians, the investment fund plans to manufacture larger amounts of vaccine for sale abroad.
Russian Health Minister Mikhail Murashko told official news firm Tass this week that of the 40,000 volunteers announced for Phase 3 testing, more than three hundred had been vaccinated so far, not counting on the fitness staff or teachers who volunteered for vaccination. and it’s not known how many have done it.
Murashko added that the vaccine will be available more widely to the general population by the end of November or December. The Russian Ministry of Health did not respond to requests for comment.
Officials in Beijing and Moscow say that everyone who receives the vaccine is voluntary and that vaccines are safe.
Russian President Vladimir Putin his daughter had taken Sputnik V adverse reaction or a case of single infection. “
But both countries have strong controls over discourse. Many expressions of fear have been indirect, in the United States, where the debate on vaccine safety has broken loose.
In statements to state media last week, Zhou of Sinopharm stated that the public involved in the protection of vaccines is not yet indicated for use in pregnant or nursing women, he added, given the lack of studies on this demographic.
Vaccine protection scandals are widespread in China, and polls showed the highest degrees of public skepticism, and a 2019 study reported that 70% of respondents did not accept vaccination as true.
In Russia, an August vote found that 54% of the more than 1,600 people who voted said they were not in a position to volunteer for vaccination, according to the Independent Levada Center.
Semyon Galperin, head of the doctors’ rights group, the Defense League, said some doctors feared they were stressed to get vaccinated. remedies for patients with coronavirus if they refuse vaccination.
Leigh Turner, an associate professor at the University of Minnesota Bioethics Center, said hasty implementations in both countries and top-down emergency use plans question the informed consent of early recipients.
“When you have reports, for example, that members of the military are given something, for me you can ask questions: can those Americans refuse?” he said.
ONLINE ADVERTISING
Contact: Sirintip Yutika Mobile 80818 8187
Email: [email protected]